Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 45.20
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 134.41m
  • Volume: 180,422
  • Market Cap: £20.16m
  • RiskGrade: 594
  • Beta: 0.01

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Sareum shares drop on product licence termination

By Benjamin Chiou

Date: Tuesday 31 Dec 2024

(Sharecast News) - Autoimmune disease and cancer treatment developer Sareum has revealed that the commercial licence of its jointly developed SRA737 product has been terminated by a biopharma company in the US.

Sareum shares rise on China patent allowance

By Josh White

Date: Monday 16 Sep 2024

(Sharecast News) - Cambridge-based biotechnology firm Sareum Holdings announced on Monday that it has received a notice of allowance from the China National Intellectual Property Administration for its patent application concerning crystalline forms of SDC-1801.

HTTP/1.1 200 OK Date: Sun, 25 May 2025 07:08:01 GMT Server: Apache Set-Cookie: splash_page_count=8; domain=digitallook.com; path=/ Set-Cookie: buffer=splash_page_count%3d1; domain=digitallook.com; path=/ Location: http://static.digitallook.com/maintenance.html Connection: close Transfer-Encoding: chunked Content-Type: text/html; charset=iso-8859-1 200 OK

OK

The document has moved here.